Your browser doesn't support javascript.
loading
An accelerated rabies vaccine schedule based on toll-like receptor 3 (TLR3) agonist PIKA adjuvant augments rabies virus specific antibody and T cell response in healthy adult volunteers.
Wijaya, Limin; Tham, Christine Y L; Chan, Yvonne F Z; Wong, Abigail W L; Li, L T; Wang, Lin-Fa; Bertoletti, Antonio; Low, Jenny G.
Afiliación
  • Wijaya L; Department of Infectious Diseases, Singapore General Hospital, 20 College Road, Singapore 169856, Singapore. Electronic address: limin.wijaya@singhealth.com.sg.
  • Tham CYL; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), 30 Medical Drive, Singapore 117609, Singapore; NUS Graduate School for Integrative Sciences and Engineering, National University of Singapore, 28 Medical Drive, Singapore 117456, Singapore. Electronic add
  • Chan YFZ; Department of Infectious Diseases, Singapore General Hospital, 20 College Road, Singapore 169856, Singapore. Electronic address: yvonne.chan2@mohh.com.sg.
  • Wong AWL; Department of Infectious Diseases, Singapore General Hospital, 20 College Road, Singapore 169856, Singapore. Electronic address: abigail.wong.w.l@sgh.com.sg.
  • Li LT; Yisheng Biopharma (Singapore) Pte. Ltd., 20 Maxwell Road, Maxwell House 07-15A, Singapore 069113, Singapore. Electronic address: lietao.li@gmail.com.
  • Wang LF; Program in Emerging Infectious Diseases, DUKE-NUS Medical School, 8 College Road, Singapore 169857, Singapore. Electronic address: linfa.wang@duke-nus.edu.sg.
  • Bertoletti A; Program in Emerging Infectious Diseases, DUKE-NUS Medical School, 8 College Road, Singapore 169857, Singapore; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), 30 Medical Drive, Singapore 117609, Singapore. Electronic address: antonio@duke-nus.edu.sg.
  • Low JG; Department of Infectious Diseases, Singapore General Hospital, 20 College Road, Singapore 169856, Singapore. Electronic address: jenny.low@singhealth.com.sg.
Vaccine ; 35(8): 1175-1183, 2017 02 22.
Article en En | MEDLINE | ID: mdl-28118938
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Antirrábicas / Linfocitos T CD4-Positivos / Adyuvantes Inmunológicos / Receptor Toll-Like 3 / Anticuerpos Neutralizantes / Anticuerpos Antivirales Tipo de estudio: Clinical_trials Límite: Adult / Animals / Humans / Male Idioma: En Revista: Vaccine Año: 2017 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas Antirrábicas / Linfocitos T CD4-Positivos / Adyuvantes Inmunológicos / Receptor Toll-Like 3 / Anticuerpos Neutralizantes / Anticuerpos Antivirales Tipo de estudio: Clinical_trials Límite: Adult / Animals / Humans / Male Idioma: En Revista: Vaccine Año: 2017 Tipo del documento: Article Pais de publicación: Países Bajos